Lexicon Pharmaceuticals Growth Metrics (2009-2012) | LXRX

Growth Metrics Jun2009 Sep2009 Dec2009 Mar2010 Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012
Growth Ratios
Assets Growth (1y) 67.40%49.45%65.80%42.33%-16.08%-13.48%-20.54%17.34%17.29%20.62%21.42%
Assets Growth (3y) 18.11%15.97%16.95%
Assets (QoQ) -0.05%-8.45%15.23%58.76%-10.77%1.57%-1.08%-6.40%-8.01%-6.71%46.08%-6.44%-5.40%-6.09%
Capital Expenditures Growth (1y) -210.90%1,317.44%618.03%-62.20%204.54%-70.58%-42.41%-17.72%-53.85%-69.16%-72.53%-45.93%
Capital Expenditures Growth (3y) 51.83%45.88%41.28%-44.80%
Capital Expenditures (QoQ) 44.87%29.07%1,201.64%-172.17%315.88%-69.82%-19.62%99.61%-39.25%-40.91%14.84%11.96%-59.40%-47.37%126.00%
Cash & Equivalents Growth (1y) 1,434.40%403.80%237.90%-53.05%-92.27%-91.79%-85.60%294.66%44.20%66.17%-31.98%
Cash & Equivalents Growth (3y) 19.61%-11.76%-30.83%
Cash & Equivalents (QoQ) 190.01%27.60%60.28%158.69%-4.78%-14.42%-77.73%-57.38%1.04%50.14%510.43%-84.43%16.44%-38.54%
Cash from Investing Activities Growth (1y) 103.80%-12.09%-102.50%-26,578.28%-353.36%-11.57%3,894.94%112.43%-2,336.54%1.33%-62.13%-137.32%
Cash from Investing Activities Growth (3y) -32.90%-7.64%-28.93%-142.61%
Cash from Investing Activities (QoQ) 161.76%-4.86%-98.31%283.03%1,327.73%-102.70%-17,813.70%96.33%598.35%15.99%-41.34%-818.58%120.73%-56.65%-157.80%
Cash from Operations Growth (1y) 22.92%5.46%5.33%-12.53%0.74%-4.71%-8.51%-15.86%-25.36%7.31%-23.99%9.15%
Cash from Operations Growth (3y) 1.38%2.83%-8.40%-5.80%
Cash from Operations (QoQ) 15.01%17.75%12.35%-25.79%-4.25%17.64%-4.19%-10.96%-9.98%14.65%-11.24%-20.06%18.68%-14.17%18.50%
EBITDA Margin Growth (1y) -95589.00-119028.00-208440.00-24247.00-336720.00-271888.00-413152.00-793099.00
EBITDA Margin (QoQ) -19670.00-25878.00-52626.002,585.00-43108.00-115290.00131,567.00-309889.0021,724.00-256555.00-248380.00
EBIT Growth (1y) -5.92%-5.67%-11.47%-2.65%-16.70%-7.69%-5.93%-48.68%
EBIT Margin Growth (1y) -95589.00-119028.00-208440.00-24247.00-336720.00-271888.00-413152.00-793099.00
EBIT Margin (QoQ) -19670.00-25878.00-52626.002,585.00-43108.00-115290.00131,567.00-309889.0021,724.00-256555.00-248380.00
EBIT (QoQ) 3.34%4.50%-0.41%-14.28%3.57%-0.74%7.54%-29.93%11.02%0.91%-29.78%
EBT Growth (1y) -6.40%-12.79%-31.96%14.13%-18.40%-8.39%5.21%-47.16%
EBT Margin Growth (1y) -92219.00-126557.00-254681.006,123.00-330828.00-280967.00-382684.00-803183.00
EBT Margin (QoQ) -18813.00-24950.00-91744.0043,288.00-53151.00-153074.00169,061.00-293663.00-3290.00-254791.00-251439.00
EBT (QoQ) 3.38%4.33%-28.33%10.31%-2.42%-11.93%16.49%-23.67%6.24%2.12%-29.66%
Enterprise Value Growth (1y) -235.94%-210.90%-268.24%-109.95%27.38%33.46%37.60%-33.43%-34.27%-40.47%-43.49%
Enterprise Value Growth (3y) -48.52%-42.70%-48.84%
Enterprise Value (QoQ) -2.89%21.26%-60.28%-158.69%4.78%6.73%8.62%10.52%12.76%12.53%-95.41%9.95%8.73%10.65%
EPS (Basic) Growth (1y) 18.75%53.33%42.86%93.07%30.77%-14.29%0.00%-42.86%
EPS (Basic) (QoQ) 6.25%6.67%-621.43%87.13%46.15%-14.29%12.50%-28.57%11.11%0.00%-25.00%
FCF Margin Growth (1y) -62107.00-112202.00-150538.00-30026.00-240635.00-240408.00-332036.00-504848.00
FCF Margin (QoQ) -12595.00-12305.00-34859.00-2347.00-62690.00-50641.0085,653.00-212957.00-62462.00-142270.00-87160.00
Free Cash Flow Growth (1y) 24.23%0.73%3.43%-9.73%-3.92%-1.38%-7.66%-15.42%-23.54%8.11%-23.13%9.49%
Free Cash Flow Growth (3y) 0.92%2.57%-8.58%-4.66%
Free Cash Flow (QoQ) 14.84%17.71%8.65%-18.37%-11.57%19.95%-3.79%-12.10%-8.84%14.99%-11.27%-19.98%19.03%-13.91%18.21%
Interest Coverage Ratio Growth (1y) -2.96%-205.67%-237.37%-743.79%39.77%3.08%-20.49%-68.92%
Interest Coverage Ratio (QoQ) -11.70%-11.31%-115.32%908.90%-196.16%-15.29%5.91%233.99%-166.68%-43.33%-31.90%
Net Cash Flow Growth (1y) 331.53%-138.58%-363.15%-535.72%-116.98%101.69%128.54%194.54%-480.65%2,170.95%-227.73%-93.80%
Net Cash Flow Growth (3y) -31.66%-47.10%-43.57%-36.54%
Net Cash Flow (QoQ) 146.74%-57.87%178.69%321.95%-107.79%-187.34%-361.44%83.56%100.78%4,753.81%1,428.38%-200.97%103.03%-373.01%174.22%
Net Income Growth (1y) -6.40%-12.79%-31.84%14.13%-18.40%-8.39%5.12%-47.16%
Net Income (QoQ) 3.38%4.33%-28.33%10.31%-2.42%-11.83%16.41%-23.67%6.24%2.12%-29.66%
Net Income towards Common Stockholders Growth (1y) -6.40%-12.79%-31.84%14.13%-18.40%-8.39%5.12%-47.16%
Net Income towards Common Stockholders (QoQ) 3.38%4.33%-28.33%10.31%-2.42%-11.83%16.41%-23.67%6.24%2.12%-29.66%
Net Margin Growth (1y) -92219.00-126557.00-254349.006,123.00-330828.00-280967.00-383017.00-803183.00
Net Margin (QoQ) -18813.00-24950.00-91744.0043,288.00-53151.00-152741.00168,728.00-293663.00-3290.00-254791.00-251439.00
Operating Income Growth (1y) -5.92%-5.67%-11.47%-2.65%-16.70%-7.69%-5.93%-48.68%
Operating Income (QoQ) 3.34%4.50%-0.41%-14.28%3.57%-0.74%7.54%-29.93%11.02%0.91%-29.78%
Operating Margin Growth (1y) -95589.00-119028.00-208440.00-24247.00-336720.00-271888.00-413152.00-793099.00
Operating Margin (QoQ) -19670.00-25878.00-52626.002,585.00-43108.00-115290.00131,567.00-309889.0021,724.00-256555.00-248380.00
Profit After Tax Growth (1y) -7.12%-7.01%-21.37%-1.01%-13.65%-5.74%5.12%-47.16%
Profit After Tax (QoQ) 3.27%3.71%-0.45%-14.49%3.36%-9.21%16.41%-28.83%10.09%2.01%-29.66%
Property, Plant & Equipment (Net) Growth (1y) -9.07%-13.12%-7.95%-8.09%
Property, Plant & Equipment (Net) (QoQ) -2.12%-1.96%-1.92%-2.20%-2.27%
Return on Assets Growth (1y) 7.0011.008.0011.00-1.00-7.00-6.00-5.008.0017.0025.00
Return on Assets Growth (3y) 15.0020.0027.00
Return on Assets (QoQ) 0.00-1.00-2.0010.003.00-3.001.00-2.00-3.00-2.002.0011.005.006.00
Return on Capital Employed Growth (1y) 8.0022.0021.003.00-6.00-9.00-7.00
Return on Capital Employed (QoQ) 1.0015.006.00-1.000.00-3.00-3.00-3.002.00
Return on Equity Growth (1y) 44.00
Return on Equity (QoQ) 8.0019.007.0010.00
Return on Sales Growth (1y) -922.00-1266.00-2543.0061.00-3308.00-2810.00-3830.00-8032.00-2141.00-3783.00-2514.00
Return on Sales Growth (3y) -6371.00-7859.00-8888.00
Return on Sales (QoQ) -188.00-249.00-917.00433.00-532.00-1527.001,687.00-2937.00-33.00-2548.00-2514.002,955.00-1676.00-1279.00
Revenue Growth (1y) -60.63%-58.75%-63.35%-11.26%-63.68%-54.99%-54.55%-72.63%
Revenue (QoQ) -28.29%-28.71%-33.74%16.22%-24.86%-36.66%60.44%-52.43%-6.88%-36.04%-3.38%
Share-based Compensation Growth (1y) -9.50%-2.65%4.14%27.09%12.80%9.85%7.43%-10.99%16.71%10.00%11.17%17.52%
Share-based Compensation Growth (3y) 6.01%5.56%7.54%9.96%
Share-based Compensation (QoQ) -5.96%-5.60%-6.56%9.11%1.15%0.98%14.03%-3.16%-1.49%-1.24%-5.52%26.98%-7.16%-0.19%-0.13%
Shareholder's Equity Growth (1y) -66.34%20.46%26.11%49.14%
Shareholder's Equity (QoQ) -12.72%75.58%-9.61%-8.95%3.21%
Total Debt Growth (1y) 44.24%-57.47%-57.47%-56.48%-43.21%-12.22%-12.60%-12.97%-5.40%-5.60%
Total Debt Growth (3y) -18.25%-29.37%
Total Debt (QoQ) -0.96%-3.23%-30.52%-36.13%-0.94%-1.00%-9.33%-1.29%-1.37%-1.42%-1.44%-1.50%